Browse the full management transaction log of Community Healthcare Trust Inc, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Community Healthcare Trust Inc has published 48 public disclosures. Market capitalisation: €467.5m. The latest transaction was filed on 23 May 2022 — Attribution. Among the most active insiders: Gardner Alan. The full history is openly available.
25 of 48 declarations
Community Healthcare Trust Incorporated (NYSE: CHCT) is a U.S.-listed healthcare real estate company headquartered in Franklin, Tennessee, in the United States. Founded in 2014 and listed in May 2015, the company operates as a fully integrated healthcare REIT focused on acquiring, owning, and managing properties leased to healthcare operators. Its business model is built around long-duration leases and a diversified tenant base, making it a specialized real estate vehicle with exposure to a defensive corner of the U.S. healthcare ecosystem. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1631569/000163156925000015/chct-20241231.htm?utm_source=openai)) CHCT’s operating footprint is centered on healthcare-related real estate rather than healthcare products or services. The company owns assets used by hospitals, physicians, specialty care providers, healthcare systems, and other medical service operators. As of December 31, 2024, the portfolio comprised roughly $1.2 billion of gross investments across 200 properties in 36 states, totaling about 4.4 million square feet. Occupancy was approximately 90.9%, and the weighted-average remaining lease term was about 6.7 years, which supports a relatively visible rent stream, although results still depend on tenant credit quality and occupancy trends. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1631569/000163156925000015/chct-20241231.htm?utm_source=openai)) From a competitive standpoint, Community Healthcare Trust occupies a niche within healthcare real estate: it is smaller and more specialized than large diversified REITs, and its edge comes from sector expertise, underwriting discipline, and the ability to source and structure healthcare-property transactions. The company has also highlighted the depth of its management team’s experience in healthcare, real estate, and public REIT operations as a key competitive strength. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1631569/000114036125008522/ef20045405_ars.pdf?utm_source=openai)) Geographically, the portfolio is broadly spread across the United States, which helps reduce concentration risk in any single state or local market. In 2024, CHCT acquired nine properties for about $72.1 million, with estimated yields in the 9.10% to 9.75% range, indicating an acquisition-led growth strategy focused on yield and lease quality. The company also reported 2024 dividends totaling $1.845 per share, reflecting ongoing income generation and a continued emphasis on shareholder returns. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001631569/000163156925000023/chct-20250312.htm?utm_source=openai)) Recent developments remain relevant for investors following SEC Form 4 insider activity and operating updates. In February 2026, CHCT reported fourth-quarter 2025 earnings of about $14.4 million in net income and disclosed the acquisition of a Florida inpatient rehabilitation facility that was 100% leased through 2040. Earlier 2025 filings and releases show continued portfolio activity and disciplined capital deployment. For francophone investors, the key takeaway is that CHCT is a specialized U.S. healthcare REIT traded on the NYSE in the United States, with a strategy centered on long-term leased medical real estate, portfolio diversification, and steady dividend-oriented growth. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1631569/000163156926000013/earningspressrelease2025q4.htm?utm_source=openai))